Monte Carlo Simulation for the Pharmaceutical Industry: Concepts, Algorithms, and Case Studies (Chapman & Hall CRC Biostatistics Series)

✍ Scribed by Mark Chang

Tongue: English
Leaves: 566
Category: Library

⬇ Acquire This Volume

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monte Carlo Simulation for the Pharmaceu

📁 Monte Carlo Simulation for the Pharmaceutical Industry: Concepts, Algorithms, and Case Studies

✍ Mark Chang (Author) 📂 Library 📅 2010 🏛 CRC Press

Helping you become a creative, logical thinker and skillful "simulator," Monte Carlo Simulation for the Pharmaceutical Industry: Concepts, Algorithms, and Case Studies provides broad coverage of the entire drug development process, from drug discovery to preclinical and clinical trial aspects to

Medical Statistics for Cancer Studies (C

📁 Medical Statistics for Cancer Studies (Chapman & Hall/CRC Biostatistics Series)

✍ Trevor F. Cox 📂 Library 📅 2022 🏛 Chapman and Hall/CRC 🌐 English

Cancer is a dreaded disease. One in two people will be diagnosed with cancer within their lifetime. Medical Statistics for Cancer Studies shows how cancer data can be analysed in a variety of ways, covering cancer clinical trial data, epidemiological data, biologic

Multiple Testing Problems in Pharmaceuti

📁 Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall CRC Biostatistics Series)

✍ Alex Dmitrienko, Ajit C. Tamhane, Frank Bretz 📂 Library 📅 2009 🏛 Chapman and Hall/CRC 🌐 English

Useful Statistical Approaches for Addressing Multiplicity IssuesIncludes practical examples from recent trials Bringing together leading statisticians, scientists, and clinicians from the pharmaceutical industry, academia, and regulatory agencies, Multiple Testing Problems in Pharmaceutical Statis

Statistical Design and Analysis of Stab

📁 Statistical Design and Analysis of Stability Studies (Chapman & Hall Crc Biostatistics Series)

✍ Shein-Chung Chow 📂 Library 📅 2007 🌐 English

The US Food and Drug Administration's Report to the Nation in 2004 and 2005 indicated that one of the top reasons for drug recall was that stability data did not support existing expiration dates. Pharmaceutical companies conduct stability studies to characterize the degradation of drug products and

Computational Pharmacokinetics (Chapman

📁 Computational Pharmacokinetics (Chapman & Hall Crc Biostatistics Series)

✍ Anders Kallen 📂 Library 📅 2007 🌐 English

Being that pharmacokinetics (PK) is the study of how the body handles various substances, it is not surprising that PK plays an important role in the early development of new drugs. However, the clinical research community widely believes that mathematics in some way blurs the true meaning of PK. De

Drug Development for Rare Diseases (Chap

📁 Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

✍ Bo Yang (editor), Yang Song (editor), Yijie Zhou (editor) 📂 Library 🌐 English

A disease is defined as rare if the prevalence is fewer than 200,000 in the United States. It is estimated that there are more than 7,000 rare diseases, which collectively affect 30 million Americans or 10% of the US population. This diverse and complex disease area poses challenges for pat